Osaic Holdings’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
Other funds holding IMVT
DTC
BBA
TCM
VPM
VCM
Osaic Holdings's IMVT Position: Q1 2026 in Review
Osaic Holdings reduced its Immunovant (IMVT) stake by 28% in Q1 2026, selling an estimated $18.7K and leaving 1,875 shares worth $46.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5280.
Osaic Holdings first reported a position in IMVT in Q3 2020 and has held it in 21 quarters since. The position peaked at $166K in Q4 2023. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.
- Osaic Holdings held 1,875 shares of Immunovant worth $46.6K as of Q1 2026.
- Osaic Holdings sold 723 Immunovant shares in Q1 2026, an estimated $18.7K.
- Immunovant made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5280 holding.
- Osaic Holdings first reported a position in Immunovant in Q3 2020 and has held it in 21 quarters since.
- Osaic Holdings's Immunovant position peaked at $166K in Q4 2023.
- 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.
Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.